Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?
Shalini Shalini, Vipan Kumar
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 4, pp. 335-363
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 94
Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kα inhibitors
Changqun Liu, Yuening Cao, Yi Y. Zuo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking
Luka Krstulović, Marijana Jukić, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 540-540
Open Access | Times Cited: 15
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
Hybrid Molecules Containing Naphthoquinone and Quinolinedione Scaffolds as Antineoplastic Agents
Ines Mancini, Jacopo Vigna, Denise Sighel, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4948-4948
Open Access | Times Cited: 22
Thiadiazole – A promising structure in design and development of anti-Alzheimer agents
Maryam Hatami, Zahra Basri, Batool Khani Sakhvidi, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110027-110027
Closed Access | Times Cited: 12
Synthesis of Novel Artemisinin, Ciprofloxacin, and Norfloxacin Hybrids with Potent Antiplasmodial Activity
Georgia Vamvoukaki, Antonia I. Antoniou, Michel Baltas, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 142-142
Open Access | Times Cited: 3
Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent
Haoyi Yang, Dongyu Zhang, Ziyang Yuan, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116205-116205
Closed Access | Times Cited: 3
Design, synthesis, molecular docking and biological evaluation of novel pyrazole derivatives bearing quinoxalinone moiety as multi-targeted anticancer agents
Cynthia E. Theodore, A.M. Anusuya, G. Sivaiah, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135765-135765
Closed Access | Times Cited: 10
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
Elena Marchesi, Daniela Perrone, Maria Luisa Navacchia
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2185-2185
Open Access | Times Cited: 10
Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety
Lina Fernanda Castaño, Jairo Quiroga, Rodrigo Abonı́a, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12589-12589
Open Access | Times Cited: 15
Self-Assembled Molecular Complexes of 1,10-Phenanthroline and 2-Aminobenzimidazoles: Synthesis, Structure Investigations, and Cytotoxic Properties
Kameliya Anichina, Nikolay Kaloyanov, Diana Zasheva, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 583-583
Open Access | Times Cited: 2
Recent Advances in the Development of Hybrid Drugs
Tânia S. Morais
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 889-889
Open Access | Times Cited: 2
Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids
Sophia Grigoropoulou, Dimitra Manou, Antonia I. Antoniou, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3623-3623
Open Access | Times Cited: 10
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
Jacinta O. Pinho, Mariana Matias, Vanda Marques, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114021-114021
Open Access | Times Cited: 10
Progress and Development of Carbazole Scaffold Based as Potential Anti- Alzheimer Agents Using MTDL Approach
Nitin Kumar, Pankaj Gupta, Sahil Bansal
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 12, pp. 1049-1067
Closed Access | Times Cited: 9
Synthesis and SAR of Potential Anti-Cancer Agents of Quinoline Analogues: A Review
Sonakshi Tyagi, Salahuddin Salahuddin, Avijit Mazumder, et al.
Medicinal Chemistry (2023) Vol. 19, Iss. 8, pp. 785-812
Closed Access | Times Cited: 5
Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update
Devendra Singh Negi, Irshad Ahmad, Donna J. Nelson, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1877-1898
Closed Access | Times Cited: 1
Synthesis of 5-oxo-1-[4-(aminosulfonyl)phenyl]pyrrolidine-3-carboxylic acids
С. А. Серков, Natalya V. Sigay, N. N. Kostikova, et al.
Russian Chemical Bulletin (2024) Vol. 73, Iss. 5, pp. 1273-1279
Closed Access | Times Cited: 1
Novel 1,2,3-Triazole-Containing Quinoline–Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking
Luka Krstulović, Katarina Mišković Špoljarić, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6950-6950
Open Access | Times Cited: 4
Therapeutic significance of molecular hybrids for breast cancer research and treatment
Devendra Singh Negi, Irshad Ahmad
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 218-238
Open Access | Times Cited: 7
Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
Darius P. Zlotos, Thales Kronenberger, Stefan Laufer
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 67-67
Open Access | Times Cited: 6
New chimeric HDAC inhibitors for the treatment of colorectal cancer
Sofia I. Bär, Rohan Pradhan, Bernhard Biersack, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Open Access | Times Cited: 5
Synthesis, In vitro Cytotoxicity, Molecular docking of Few Quinazolinone Incorporated Naphthyl Chalcones: As Potential Dual Targeting Anticancer Agents to Treat Lung Cancer and Colorectal Cancer
Praveen Kumar Arora, Sushil Kumar, Sandeep Kumar Bansal, et al.
Oriental Journal Of Chemistry (2023) Vol. 39, Iss. 2, pp. 231-245
Open Access | Times Cited: 2
A Review of In Vitro Antimicrobial Activities of Carbazole and its Derivative From 2014 to 2022
Nitin Kumar, Shalini Sharma, Puneet Nirmal
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top